Effect of GutGard in the Management of Helicobacter pylori: A Randomized Double Blind Placebo Controlled Study

Table 3

Proportion of subjects turned from H. pylori—positive (Hp⁺) to negative (Hp⁻) status as measured by HpSA and ¹³C-UBT.

Groups	Days	𝑛	HpSA		^13C-UBT
			Hp^+	Hp^− (%)	Hp^+	Hp^− (%)
GutGard	0	50	50	0 (0)	50	0 (0)
Placebo		50	50	0 (0)	50	0 (0)
GutGard	30	50	50	0 (0)	50	0 (0)
Placebo		50	50	0 (0)	50	0 (0)
GutGard	60	50	22	28* (56)	26	24* (48)
Placebo		50	48	2 (4)	49	1 (2)

𝑛: no. of subjects; Hp⁻: H. pylori negative; Hp⁺: H. pylori positive.
%: percentage of subjects turned from Hp Positive to Hp Negative.
∗Significant difference compared to placebo.